There were 2,445 press releases posted in the last 24 hours and 441,518 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image